Qtrex Quantum Ltd. · NASDAQ:QTEX

Qtrex Quantum — Inspira Technologies OXY B.H.N. — Investor Presentation (November 2024)

12 slides from Qtrex Quantum's investor presentation, Nov 12, 2024

  1. Slide 1: Inspira Technologies Webinar November 2024

    See Disclaimers on slides 1 - 16 . Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 1 See Disclaimers in deck on slides 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 1 Inspira Technologies WEBINAR NOVEMBER 2024

  2. Slide 2: Forward Looking Statement Disclaimer

    See Disclaimers on slides 2 - 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 2 This presentation contains express or implied forward - looking statements pursuant to U . S . Federal securities laws . These forward - looking statements and their implications are b

  3. Slide 3: Disclaimers

    See Disclaimers on slides 2 - 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 3 The reference to INSPIRA TM ART should be interpreted as the fact that it is a platform. The use of the term INSPIRA TM ART can refer to the INSPIRA TM ART 500 or INSPIRA TM ART Gen 2

  4. Slide 4: The dark side of ventilators

    See Disclaimers on slides 2 - 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 4 “ Why some doctors are moving away from ventilators ” “ The dark side of ventilators ” Patients can often experience legacy complications: delirium, lung infections, lung injury or sev

  5. Slide 5: Millions May Soon Breathe Better (Forbes)

    See Disclaimers on slides 2 - 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 5 “ A new and innovative direct blood oxygenation technology may provide a solution . Augmented Respiration Technology, (ART), developed by Inspira Technologies , tackles the increased g

  6. Slide 6: INSPIRA ART: Straight into the Blood

    See Disclaimers on slides 2 - 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 6 Straight into the Blood INSPIRA ART A breakthrough technology that could disrupt the $ 19 Billion * Mechanical Ventilation Market $ 19 Billion Predicted Global Mechanical Ventilation M

  7. Slide 7: INSPIRA ART patient benefits

    See Disclaimers on slides 2 - 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 7 Patient treated while awake No coma and weaning No tube in throat No lung infection or injury Rapidly boosts oxygen saturation levels within minutes, potentially enabling treatment of

  8. Slide 8: Disruptive Core Technologies of INSPIRA ART

    See Disclaimers on slides 2 - 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 8 Disruptive Core Technologies of INSPIRA ART VORTX A Direct Oxygenation Delivery Technology Being designed to defuse oxygen into the blood and remove carbon dioxide with minimal contact

  9. Slide 9: INSPIRA ART 100 Cardiopulmonary Bypass FDA 510(k)-cleared

    See Disclaimers on slides 2 - 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 9 *The INSPIRA ART 100 System is FDA 510 (k) cleared for use in an extracorporeal perfusion circuit to pump blood during short - duration cardiopulmonary bypass procedures lasting 6 hour

  10. Slide 10: INSPIRA ART - Pathway to Market Disruption

    10 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved Collaboration with leading medical centers and global medical device companies o Use of FDA - Cleared proprietary and core technologies in high - stakes medical environments for collection of clinical evidence Categ

  11. Slide 11: Inspired Team

    See Disclaimers on slides 2 - 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 11 Dr. Daniella Yeheskely - Hayon, PhD CTO Renowned Expert in the field of Artificial Lung Development Yafit Tehila , CPA CFO & Legal Serial Financial management experience in public com

  12. Slide 12: Targeting to Disrupt the $19 Billion Mechanical Ventilation Market

    See Disclaimers on slides 1 - 16 . Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 12 See Disclaimers in deck on slides 3 Copyright © 2018 - 2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved 12 TARGETING TO DISRUPT THE $ 19 BILLION MECHANICAL VENTILATIO

Inspira Technologies OXY B.H.N. — Investor Presentation (November 2024) on 6ix